These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 18562410

  • 1. Rapid dose-dependent effect of clozapine on a schizophrenic patient's lipid profile.
    Chiang HL, Liu CC, Hwang TJ.
    J Psychopharmacol; 2009 Jun; 23(4):465-7. PubMed ID: 18562410
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Relationship between clozapine plasma levels and withdrawal symptoms].
    Berecz R, de la Rubia Martínez A, Norberto Gamero MJ, Gutiérrez Casares JR, Glaub T, Degrell I, Llerena A.
    Actas Esp Psiquiatr; 2002 Jun; 30(6):397-9. PubMed ID: 12487951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clozapine-induced severe mixed hyperlipidemia: a case report.
    Ahmed M, Griffin D, O'Toole R, McDonald C.
    Gen Hosp Psychiatry; 2009 Jun; 31(1):93-6. PubMed ID: 19134516
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prescribing and monitoring clozapine in Christchurch.
    McKean A, Vella-Brincat J, Begg E.
    Australas Psychiatry; 2008 Aug; 16(4):263-7. PubMed ID: 18668375
    [Abstract] [Full Text] [Related]

  • 13. Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy.
    Floreani J, Bastiampillai T.
    Aust N Z J Psychiatry; 2008 Aug; 42(8):747-8. PubMed ID: 18642408
    [No Abstract] [Full Text] [Related]

  • 14. Cardiomyopathy associated with clozapine.
    Roh S, Ahn DH, Nam JH, Yang BH, Lee BH, Kim YS.
    Exp Clin Psychopharmacol; 2006 Feb; 14(1):94-8. PubMed ID: 16503709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies.
    Zipris P, Melamed Y, Weizman A, Bleich A.
    Isr J Psychiatry Relat Sci; 2007 Feb; 44(1):54-6. PubMed ID: 17665812
    [Abstract] [Full Text] [Related]

  • 17. Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.
    Wysokiński A, Sobów T.
    Nord J Psychiatry; 2016 Feb; 70(2):156-60. PubMed ID: 26140393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The association between dyslipidaemia and types of antipsychotic medications among patients with chronic schizophrenia.
    Ruzanna ZZ, Ong LY, Cheah YC, Fairuz A, Marhani M.
    Med J Malaysia; 2012 Feb; 67(1):39-44. PubMed ID: 22582547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.